Replies to post #235218 on Biotech Values

[DewDiligence]

ABT sold $880M of COVID-19 diagnostics in 3Q20! The 4Q20 figure is expected to be >=$1.3B.

[DewDiligence]

ABT sold $2.4B of COVID-19 diagnostics during 4Q20!

https://abbott.mediaroom.com/2021-01-27-Abbott-Reports-Fourth-Quarter-2020-Results-Issues-Strong-Double-Digit-Growth-Forecast-for-2021

Non-GAAP EPS guidance for 2021 is >=$5.00, +37% (or more) relative to 2020’s $3.65.